Health coaching program for adults with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PACT Study is a cluster randomized trial that evaluates the effectiveness of a health coaching intervention for adults with sub-optimally controlled type 2 diabetes. Participants will receive personalized coaching from trained laypersons, known as Care Coaches, over a 3-month period, focusing on lifestyle changes and diabetes management. The study compares outcomes such as Glycated Hemoglobin (HbA1c) levels, blood pressure, and quality of life between those receiving the PACT program and those receiving usual care. The trial aims to determine if this intervention can lead to significant improvements in diabetes control and overall health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals with a diagnosis of Type 2 Diabetes Mellitus who are enrolled in Teamlets in NHGP
* Age between 21 to 64 years old
* HbA1c level of more than 8% in the last 6 months

Exclusion Criteria:

* History of acute coronary syndrome in the past 3 months
* History of stroke or transient ischaemic attacks in the past 3 months
* History of end stage organ failure (liver cirrhosis, cardiac failure, latest eGFR \<30 mL/min/1.73m2 in the last 6 months)
* Cancer requiring treatment in the past 5 years.
* Active psychiatrist follow up
* Social issues that are significant enough for follow-up or referral with a medical social worker within the last 12 months
* Women who are pregnant or breastfeeding
* Patients who are enrolled in other current diabetes-related interventional studies
* Inability to provide written consent for the study protocol and able to commit to the study duration.

Where it's running

• NHGP Woodlands Polyclinic
  Singapore, Singapore Recruiting
• NHGP Geylang Polyclinic
  Singapore, Singapore Not yet recruiting
• NHGP Ang Mo Kio Polyclinic
  Singapore, Singapore Not yet recruiting

Study contacts

• Principal investigator: Sabrina Kay Wye Wong, MBBS — National Healthcare Group Polyclinics
• Study coordinator: Jun Hwee Benjamin Lee, MBBS
• Email: benjamin_jh_lee@nhgp.com.sg
• Phone: +6563553000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes

  This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.

  Recruiting Maxima Medical Center · Eindhoven, North Brabant · NCT07812623

• What personal, social, and access factors affect taking diabetes medicines

  This project will see if patients' knowledge, beliefs, family support, healthcare communication, and access problems influence how adults with diabetes take their medicines.

  Recruiting University of Malaya · Ambāla, Haryana · NCT07420634

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

• iLet Bionic Pancreas started through primary care for adults on insulin

  This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.

  Recruiting University of Colorado, Denver · Aurora, Colorado and 1 other locations · NCT07011147

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.